Position in NVS
as of Jun 30, 2026
· filed Jul 7, 2026
Position Value
$45,135
+$1,143 QoQ
Shares Held
288
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#1,439
of 1,603 holders
Holding Since
Sep 2023
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Arlington Trust Co LLC holds $1,296,049 across 14 Drug Manufacturers - General names. NVS ranks #6 (3.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
278 | $333,441 | |
| 2 | ABBV |
AbbVie Inc.
|
1,150 | $289,386 | |
| 3 | MRK |
Merck & Co., Inc.
|
1,750 | $224,875 | |
| 4 | JNJ |
Johnson & Johnson
|
771 | $195,810 | |
| 5 | AMGN |
Amgen Inc
|
254 | $91,978 | |
| 6 | NVS |
Novartis AG
This page
|
288 | $45,135 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
610 | $35,148 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
212 | $26,784 |
All Filings in NVS
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $45,135 | 288 | Shares | Sole | 2026-07-07 | |
| 2026-03-31 | $43,992 | 288 | Shares | Sole | 2026-04-08 | |
| 2025-12-31 | $24,678 | 179 | Shares | Sole | 2026-01-30 | |
| 2025-06-30 | $605 | 5 | Shares | Sole | 2025-07-08 | |
| 2023-12-31 | $2,019 | 20 | Shares | Sole | 2024-01-24 | |
| 2023-09-30 | $2,956,588 | 29,026 | Shares | Sole | 2023-10-24 | |
| No filing history on record for this holder in this stock. | ||||||